Literature DB >> 33750863

Hair and salivary cortisol and their relationship with lifestyle, mood and cognitive outcomes in premanifest Huntington's disease.

Travis Cruickshank1,2,3, Tenielle Porter1,2,4, Simon M Laws1,2,4, Mel Ziman5,6, Danielle M Bartlett7,8.   

Abstract

Salivary cortisol dysrhythmias have been reported in some, but not all studies assessing hypothalamic-pituitary-adrenal (HPA) axis function in Huntington's disease (HD). These differences are presumed to be due to environmental influences on temporal salivary cortisol measurement. Further exploration of HPA-axis function using a more stable and longer-term measure, such as hair cortisol, is needed to confirm earlier findings. This study aimed to evaluate hair and salivary cortisol concentrations and their associations with clinical and lifestyle outcomes in individuals with premanifest HD (n = 26) compared to healthy controls (n = 14). Participants provided saliva and hair samples and data were collected on clinical disease outcomes, mood, cognition, physical activity, cognitive reserve, sleep quality and social network size to investigate relationships between clinical and lifestyle outcomes and cortisol concentrations. Hair and salivary cortisol concentrations did not significantly differ between the premanifest HD and control groups. No significant associations were observed between hair or salivary cortisol concentrations and cognitive, mood or lifestyle outcomes. However, hair cortisol concentrations were significantly associated with disease outcomes in individuals with premanifest HD. Significant associations between hair cortisol concentrations and measures of disease burden and onset may suggest a potential disease marker and should be explored longitudinally in a larger sample of individuals with HD.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33750863      PMCID: PMC7943576          DOI: 10.1038/s41598-021-84726-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  38 in total

1.  Associations between diurnal cortisol patterns and lifestyle factors, psychotic symptoms, and neurological deficits: A longitudinal study on patients with chronic schizophrenia.

Authors:  Rainbow T H Ho; Ted C T Fong; Adrian H Y Wan; Friendly S W Au-Yeung; Eric Y H Chen; David Spiegel
Journal:  J Psychiatr Res       Date:  2016-06-18       Impact factor: 4.791

2.  Positive and negative social support and HPA-axis hyperactivity: Evidence from glucocorticoids in human hair.

Authors:  Eleonora Iob; Clemens Kirschbaum; Andrew Steptoe
Journal:  Psychoneuroendocrinology       Date:  2018-06-12       Impact factor: 4.905

3.  Cortisol and depression in pre-diagnosed and early stage Huntington's disease.

Authors:  Christopher A Shirbin; Phyllis Chua; Andrew Churchyard; Georgia Lowndes; Anthony J Hannan; Terence Y Pang; Edmond Chiu; Julie C Stout
Journal:  Psychoneuroendocrinology       Date:  2013-09-26       Impact factor: 4.905

Review 4.  Hypothalamic-endocrine aspects in Huntington's disease.

Authors:  Asa Petersén; Maria Björkqvist
Journal:  Eur J Neurosci       Date:  2006-08-21       Impact factor: 3.386

5.  Levels of cortisol and neurotrophic factor brain-derived in Parkinson's disease.

Authors:  Camila Medeiros Costa; Gabriella Luciana de Oliveira; Angélica Cristina Sousa Fonseca; Raquel de Carvalho Lana; Janaíne Cunha Polese; Andrei Pereira Pernambuco
Journal:  Neurosci Lett       Date:  2019-06-29       Impact factor: 3.046

6.  The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening.

Authors:  F Hucklebridge; T Hussain; P Evans; A Clow
Journal:  Psychoneuroendocrinology       Date:  2005-01       Impact factor: 4.905

7.  Cognitive reserve and brain reserve in prodromal Huntington's disease.

Authors:  Aaron Bonner-Jackson; Jeffrey D Long; Holly Westervelt; Geoffrey Tremont; Elizabeth Aylward; Jane S Paulsen
Journal:  J Int Neuropsychol Soc       Date:  2013-05-23       Impact factor: 2.892

8.  Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.

Authors:  J Kassubek; F D Juengling; T Kioschies; K Henkel; J Karitzky; B Kramer; D Ecker; J Andrich; C Saft; P Kraus; A J Aschoff; A C Ludolph; G B Landwehrmeyer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

9.  Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease.

Authors:  X Du; L Leang; T Mustafa; T Renoir; T Y Pang; A J Hannan
Journal:  Transl Psychiatry       Date:  2012-07-03       Impact factor: 6.222

Review 10.  Sleep Disorders in Huntington's Disease.

Authors:  Radoslawa Herzog-Krzywoszanska; Lukasz Krzywoszanski
Journal:  Front Psychiatry       Date:  2019-04-12       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.